Testosterone replacement therapy occupies two extreme positions in the public imagination. In men’s health marketing, it’s the solution to every problem middle age produces — restore your youthful energy, lose fat, build muscle, reclaim your libido, become the man you used to be. In more cautious medical discourse, it’s a medication with significant risks that requires careful selection, monitoring, and indefinite management.
Reality lands between these poles. TRT is an effective, well-studied treatment for men with confirmed testosterone deficiency and symptomatic impairment. For the right candidate, managed properly, the benefits are genuine and meaningful. For the wrong candidate, started without proper evaluation and monitored inadequately, the risks are real and the benefits limited.
Understanding the evidence allows men to have informed conversations with their physicians — approaching TRT neither as a cure-all nor as something categorically to be avoided.
Who TRT Is Appropriate For
The Endocrine Society’s clinical guidelines establish clear criteria for testosterone therapy [1]:
- Consistently low serum testosterone — below normal range on two separate morning samples (total testosterone typically below 300 ng/dL, though free testosterone and clinical context matter)
- Symptoms consistent with testosterone deficiency — reduced libido, erectile dysfunction, depressed mood, fatigue, reduced muscle mass, hot flashes, or other established symptoms
- Other causes ruled out or addressed — sleep apnea evaluated, thyroid function tested, medications with testosterone-suppressing effects reviewed, significant obesity addressed
The third criterion is frequently overlooked in practice. Starting testosterone replacement in a man with undiagnosed sleep apnea, untreated hypothyroidism, or medication-induced testosterone suppression treats the number rather than the person — and may produce suboptimal results while missing a more easily correctable cause.
Who is NOT an appropriate candidate:
- Men with normal testosterone and non-specific symptoms (fatigue, mild mood changes, reduced libido) — the symptoms likely have other causes
- Men with prostate cancer or high suspicion of prostate cancer (testosterone feeds prostate cancer growth)
- Men with polycythemia (elevated red blood cell count) not adequately managed
- Men with severe untreated sleep apnea (TRT can worsen OSA)
- Men who want to preserve fertility in the near term (exogenous testosterone suppresses the HPG axis and reduces sperm production)
- Men with severe heart failure or recent cardiovascular events (the cardiovascular safety data in high-risk men is still evolving)
Delivery Methods
Intramuscular Injections
How it works: Testosterone cypionate or enanthate injected into the muscle (typically gluteal or thigh) every 1-2 weeks.
Advantages:
- Least expensive delivery method
- Highly effective
- Well-studied with decades of data
- Can be self-administered after physician instruction
Disadvantages:
- Peak-and-trough fluctuations: testosterone spikes high after injection, then declines to trough before the next dose — some men experience mood, energy, and libido fluctuations that correlate with this cycle
- More frequent injections (weekly instead of biweekly) reduce the peak-trough effect
- Requires self-injection comfort or regular physician/nurse visits
Transdermal Gels and Creams
How it works: Testosterone gel (Androgel, Testim, Axiron) or cream applied to skin daily — typically shoulders, upper arms, or abdomen — where it absorbs through the skin over 24 hours.
Advantages:
- Produces more stable testosterone levels than injections (daily application maintains consistent levels)
- Non-invasive
- Easy to adjust dose
Disadvantages:
- Transfer risk: the gel can transfer to a partner or child through skin contact before it dries — requires careful handwashing and avoiding contact for several hours post-application
- Skin irritation in some men
- More expensive than injections
- Requires daily compliance
- Absorption varies between individuals
Transdermal Patches
How it works: A testosterone patch (Androderm) applied to skin daily, releasing testosterone through the skin continuously over 24 hours.
Advantages:
- Stable daily testosterone levels
- Convenient once-daily application
Disadvantages:
- Skin irritation and adhesion issues are common complaints
- Less used than gels due to tolerability concerns
Subcutaneous Pellets
How it works: Small testosterone pellets implanted under the skin (typically the buttock or hip) by a physician, releasing testosterone slowly over 3-6 months.
Advantages:
- No daily compliance required — one procedure every 3-6 months
- Stable testosterone levels without daily variation
- No transfer risk
Disadvantages:
- Minor surgical procedure for insertion
- Dose cannot be adjusted after insertion (if too high or too low, you wait for the pellets to absorb)
- Not universally available; most common at men’s health specialty clinics
- Higher upfront cost
Oral and Buccal Formulations
Oral testosterone (testosterone undecanoate, Jatenzo in the US) avoids the liver toxicity concerns of older oral testosterone formulations. It requires twice-daily dosing with a meal and produces variable blood levels.
Buccal tablets (Striant) — placed against the gum twice daily — are less commonly used due to mouth irritation and compliance challenges.
Expected Benefits
For confirmed hypogonadal men, the documented benefits of TRT include [2]:
Sexual function: Improved libido in most hypogonadal men; improvements in erectile function (particularly in men with testosterone below 300 ng/dL) that complement PDE5 inhibitor therapy — though TRT alone is less effective than PDE5 inhibitors for vascular ED
Body composition: Increased lean muscle mass (typically 2-3 kg over 6-12 months with resistance training); reduced fat mass, particularly visceral fat; improvement in waist circumference
Mood and energy: Reduced depressive symptoms, improved sense of wellbeing, and increased energy in men with confirmed deficiency; effect sizes vary substantially between individuals
Bone density: Increased bone mineral density with long-term treatment, particularly relevant for men with osteopenia
Cognitive function: Some studies show improvements in verbal memory and spatial cognition in hypogonadal men; effects on cognition are more modest than on physical and sexual symptoms
Important expectation-setting: TRT is not a youth restoration. Men who begin TRT with testosterone of 280 ng/dL and achieve levels of 500-600 ng/dL will experience improvements, but not the function of a 25-year-old. The benefits are meaningful and real — but proportionate to the deficiency being corrected, not the gap between current age and youth.
For men looking to support sexual function alongside TRT, Mammoth Force offers products specifically designed to complement the physiological improvements that testosterone optimization initiates.
Real Risks
TRT is not without risk. Every man considering therapy deserves honest information about the following:
Erythrocytosis (Elevated Hematocrit)
Testosterone stimulates red blood cell production. Hematocrit (the percentage of blood volume occupied by red blood cells) can rise above normal range — increasing blood viscosity and theoretically increasing the risk of thrombotic events (blood clots, stroke, heart attack). This is the most common manageable adverse effect of TRT.
Management: Hematocrit is monitored regularly (every 3-6 months initially). If it rises above 54%, TRT dose is reduced, frequency adjusted, or therapeutic phlebotomy (blood donation) is used to bring levels down.
Effects on Fertility
Exogenous testosterone suppresses the HPG axis — the pituitary stops signaling the testes to produce testosterone and sperm. Most men on TRT have severely reduced sperm counts. This effect is reversible after discontinuation in most cases, but recovery takes months and is not guaranteed in all men.
Men who want biological children should discuss fertility preservation (sperm banking) before starting TRT, or consider alternative treatments (clomiphene citrate or human chorionic gonadotropin) that maintain HPG axis stimulation.
Testicular Atrophy
The suppression of endogenous testosterone production causes the testes to reduce in size and firmness. This is cosmetically concerning to some men and is reversible with treatment discontinuation, but it doesn’t occur in reverse on its own during TRT.
Sleep Apnea Exacerbation
Testosterone can worsen obstructive sleep apnea. Men with undiagnosed or inadequately treated OSA should be evaluated and treated before starting TRT.
Cardiovascular Considerations
The cardiovascular safety of TRT has been a subject of significant research and ongoing debate. Current evidence is most reassuring for men with confirmed hypogonadism receiving standard physiological dose replacement:
- The TRAVERSE trial (the largest TRT cardiovascular safety trial, published 2023) found no significant increase in major cardiovascular events in hypogonadal men treated with testosterone gel versus placebo [3]
- Men with recent MI, unstable angina, or severe heart failure require additional caution and specialist consultation before TRT
Prostate Considerations
Long-standing clinical guidelines recommended against TRT in men with prostate cancer based on the concept that testosterone “feeds” prostate cancer growth. Current evidence has refined this view:
- TRT does not appear to increase prostate cancer risk in hypogonadal men without prior cancer
- TRT is still contraindicated in men with active or suspected prostate cancer
- PSA should be monitored regularly in all men on TRT
Monitoring Requirements
TRT requires ongoing laboratory monitoring — this isn’t optional. Standard monitoring includes:
- Testosterone levels (total and free): 6-8 weeks after initiation or dose change, then every 6-12 months
- Hematocrit/hemoglobin: Same schedule as testosterone
- PSA: At 3-6 months and annually thereafter
- Digital rectal exam: Annually in men over 50
- Lipid panel: At baseline and annually
- Bone density (DEXA): At baseline and every 1-2 years in men at osteoporosis risk
Men who refuse monitoring should not be on TRT. The risks of undertreated side effects (erythrocytosis, undiagnosed prostate issues) outweigh the benefits of continued treatment without oversight.
The Indefinite Commitment Question
Once TRT is initiated, stopping it is straightforward but produces a period of symptoms while endogenous testosterone recovers. The HPG axis typically recovers within 3-6 months after cessation, though recovery is slower in older men and those on TRT for extended periods.
Many men who benefit from TRT and stop it for any reason report wanting to restart within months — which is a reasonable decision if they meet criteria. TRT is not a permanent, irreversible commitment. But it is a long-term management decision rather than a course of treatment with a defined endpoint.
Key Takeaways
- TRT is appropriate for confirmed hypogonadal men with symptoms — not for men with normal testosterone or non-specific symptoms without documented deficiency
- Multiple delivery methods exist with different profiles: injections (affordable, effective, fluctuating), gels (stable, transfer risk), pellets (convenient, no dose adjustment), oral (limited use)
- Documented benefits include improved libido, body composition, mood, bone density, and energy — proportionate to the deficiency corrected
- Real risks include erythrocytosis, fertility effects, testicular atrophy, and sleep apnea exacerbation — all manageable with appropriate monitoring
- Cardiovascular safety in standard-dose hypogonadal treatment appears acceptable per current evidence — the TRAVERSE trial provides important reassurance
- Regular monitoring is non-negotiable — testosterone levels, hematocrit, PSA, and metabolic markers require ongoing surveillance
- TRT is a long-term management decision, not a course of treatment — many men require indefinite continuation to maintain benefits
Related Articles
- Testosterone After 40: The Complete Guide
- Understanding Testosterone Decline
- Natural Ways to Boost Testosterone After 40
- Talking to Your Doctor About Sexual Health
References
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism. 2018;103(5):1715-1744. PubMed
Isidori AM, Giannetta E, Gianfrilli D, et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clinical Endocrinology. 2005;63(4):381-394. PubMed
Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. New England Journal of Medicine. 2023;389(2):107-117. PubMed
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your health routine.
